Cell entry mechanisms of SARS-CoV-2

Shang, Jian, Wan, Yushun, Luo, Chuming, Ye, Gang, Geng, Qibin, Auerbach, Ashley, Li, Fang·2020·Proceedings of the National Academy of Sciences
DOI 10.1073/pnas.2003138117

Cited by (1,003)

Items 901–1,000 of 1,003

  1. Autophagy‐linked plasma and lysosomal membrane protein PLAC8 is a key host factor for SARS‐CoV‐2 entry into human cells
    Alejandro Pineiro Ugalde, Gabriel Bretones, David Rodríguez, Vı́ctor Quesada, Francisco Rubio Llorente, Raúl Fernández‐Delgado, Miguel Ángel Jiménez‐Clavero, Jesús Vázquez, Enrique Calvo, Isaac Tamargo‐Gómez et al. · 2022 · The EMBO Journal
  2. A Review: The Antiviral Activity of Cyclic Peptides
    Le Yi Chia, Palanirajan Vijayaraj Kumar, Marwan Abdelmahmoud Abdelkarim Maki, Guna Ravichandran, Sivasudha Thilagar · 2022 · International Journal of Peptide Research and Therapeutics
  3. In-Silico Lead Druggable Compounds Identification against SARS COVID-19 Main Protease Target from In-House, Chembridge and Zinc Databases by Structure-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations
    Mehreen Ghufran, Mehran Ullah, Haider Ali Khan, Sabreen Ghufran, Muhammad Ayaz, Muhammad Siddiq, Syed Qamar Abbas, Syed Shams ul Hassan, SIMONA GABRIELA BUNGAU · 2023 · Bioengineering
  4. Customization of aptamer to develop CRISPR/Cas12a-derived ultrasensitive biosensor
    Wenping Xing, Qian Li, Cong Han, Dongdong Sun, Zheng Zhang, Xiaona Fang, Yu Guo, Feng Ge, Wei Ding, Zhaofeng Luo et al. · 2023 · Talanta
  5. SIM imaging resolves endocytosis of SARS-CoV-2 spike RBD in living cells
    Lu Miao, Chunyu Yan, Yingzhu Chen, Wei Zhou, Xuelian Zhou, Qinglong Qiao, Zhaochao Xu · 2023 · Cell chemical biology
  6. COVID-19 Therapeutic Potential of Natural Products
    Zhaoxuan Low, Rafidah Lani, Vunjia Tiong, Chit Laa Poh, Sazaly AbuBakar, Pouya Hassandarvish · 2023 · International Journal of Molecular Sciences
  7. Nanostructures for prevention, diagnosis, and treatment of viral respiratory infections: from influenza virus to SARS-CoV-2 variants
    Esmaeel Sharifi, Satar Yousefiasl, Maria Trovato, Rossella Sartorius, Yasaman Esmaeili, Hamid Goodarzi, Matineh Ghomi, Ashkan Bigham, Farnaz Dabbagh Moghaddam, Maryam Heidarifard et al. · 2023 · Journal of Nanobiotechnology
  8. Fundamental evolution of all Orthocoronavirinae including three deadly lineages descendent from Chiroptera‐hosted coronaviruses: SARS‐CoV, MERS‐CoV and SARS‐CoV‐2
    Denis Jacob Machado, Rachel Scott, Sayal Guirales-Medrano, Daniel A. Janies · 2021 · Cladistics
  9. Dual Targeting of Toll-Like Receptor 4 and Angiotensin-Converting Enzyme 2: A proposed Approach to SARS-CoV-2 Treatment
    Laura Kate Gadanec, Tawar Qaradakhi, Kristen Renee McSweeney, Benazir Ashiana Ali, Anthony Zulli, Vasso Apostolopoulos · 2021 · Future Microbiology
  10. Functional and antigenic characterization of SARS-CoV-2 spike fusion peptide by deep mutational scanning
    Ruipeng Lei, Enya Qing, Abby E. Odle, Meng Yuan, Chaminda D. Gunawardene, Timothy J.C. Tan, Natalie So, Wenhao O. Ouyang, Ian A. Wilson, Tom Gallagher et al. · 2024 · Nature Communications
  11. Intracellular autoactivation of TMPRSS11A, an airway epithelial transmembrane serine protease
    Ce Zhang, Yikai Zhang, Shengnan Zhang, Zhiting Wang, Shijin Sun, Meng Liu, Yue Chen, Ningzheng Dong, Qingyu Wu · 2020 · Journal of Biological Chemistry
  12. Non-Receptor-Mediated Lipid Membrane Permeabilization by the SARS-CoV-2 Spike Protein S1 Subunit
    Alina Asandei, Loredana Mereuta, Irina Schiopu, Jonggwan Park, Chang Ho Seo, Yoonkyung Park, Tudor Luchian · 2020 · ACS Applied Materials & Interfaces
  13. COVID-19: The Emerging Immunopathological Determinants for Recovery or Death
    Tanveer Ahmad, Rituparna Chaudhuri, Mohan Chandra Joshi, Ahmad Almatroudi, Arshad Husain Rahmani, Syed Mansoor Ali · 2020 · Frontiers in Microbiology
  14. Challenges and Opportunities from Targeting Inflammatory Responses to SARS-CoV-2 Infection: A Narrative Review
    Vincenzo Lariccia, Simona Magi, Tiziano Serfilippi, Marwa Toujani, Santo Gratteri, Salvatore Amoroso · 2020 · Journal of Clinical Medicine
  15. Virus‐Free and Live‐Cell Visualizing SARS‐CoV‐2 Cell Entry for Studies of Neutralizing Antibodies and Compound Inhibitors
    Yali Zhang, Shaojuan Wang, Yangtao Wu, Wangheng Hou, Lunzhi Yuan, Chenguang Shen, Juan Wang, Jianghui Ye, Qingbing Zheng, Jian Ma et al. · 2020 · Small Methods
  16. Spiking dependence of SARS‐CoV‐2 pathogenicity on TMPRSS2
    Asim Z. Abbasi, Dania A. Kiyani, Syeda M. Hamid, Muhammad Saalim, Ammad Fahim, Nasir Jalal · 2021 · Journal of Medical Virology
  17. A Biochemical Perspective of the Nonstructural Proteins (NSPs) and the Spike Protein of SARS CoV-2
    Francis K. Yoshimoto · 2021 · The Protein Journal
  18. Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia
    Matthew Geriak, Fadi A. Haddad, Ravina Kullar, Kristina L. Greenwood, MacKenzie Habib, Cole Habib, David C. Willms, George Sakoulas · 2021 · Infectious Diseases and Therapy
  19. Wharton's Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles Reduce SARS-CoV2-Induced Inflammatory Cytokines Under High Glucose and Uremic Toxin Conditions
    Vương Cát Khánh, Mizuho Fukushige, Yun Hsuan Chang, Ngo Nhat Hoang, Toshiharu Yamashita, Mana Obata‐Yasuoka, Hiromi Hamada, Motoo Osaka, Yuji Hiramatsu, Osamu Ohneda · 2021 · Stem Cells and Development
  20. Extracellular Vesicles as a Means of Viral Immune Evasion, CNS Invasion, and Glia-Induced Neurodegeneration
    Miranda D. Horn, Andrew G. MacLean · 2021 · Frontiers in Cellular Neuroscience
  21. Single‐dose immunisation with a multimerised SARS‐CoV‐2 receptor binding domain (RBD) induces an enhanced and protective response in mice
    Ralf Salzer, Jordan J. Clark, Marina Vaysburd, Veronica T.-C. Chang, Anna Albecka, L. Kiss, Parul Sharma, Andres Gonzalez Llamazares, Anja Kipar, Julian A. Hiscox et al. · 2021 · FEBS Letters
  22. Identification of Niemann-Pick C1 protein as a potential novel SARS-CoV-2 intracellular target
    Isabel García-Dorival, Miguel Ángel Cuesta-Geijo, Lucía Barrado-Gil, Inmaculada Galindo, Urtzi Garaigorta, Jesús Urquiza, Ana del Puerto, Nuria Eugenia Campillo, Ana Martı́nez, Pablo Gastaminza et al. · 2021 · Antiviral Research
  23. A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance
    Mohd Anisul Karim, Jarrod Shilts, Jeremy Schwartzentruber, James D. Hayhurst, Annalisa Buniello, Elmutaz Shaikho Elhaj Mohammed, Jie Zheng, Michael Vaclav Holmes, David Ochoa, Miguel Carmona et al. · 2021 · eLife
  24. Inhibitory effect of honokiol on furin-like activity and SARS-CoV-2 infection
    Takashi Tanikawa, Tsuyoshi Hayashi, Ryuichiro Suzuki, Masashi Kitamura, Yutaka Inoue · 2021 · Journal of Traditional and Complementary Medicine
  25. Known Cellular and Receptor Interactions of Animal and Human Coronaviruses: A Review
    Holly Everest, Phoebe Stevenson-Leggett, Dalan Bailey, Erica Bickerton, Sarah Keep · 2022 · Viruses
  26. Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review
    Sebastião Freitas de Medeiros, Márcia Marly Winck Yamamoto, Matheus Antônio Souto de Medeiros, Ana Karine Lin Winck Yamamoto, Bruna Barcelo Barbosa · 2022 · Reviews in Endocrine and Metabolic Disorders
  27. Berbamine hydrochloride potently inhibits SARS-CoV-2 infection by blocking S protein-mediated membrane fusion
    Zherui Zhang, Yanan Zhang, Hong-Qing Zhang, Qiu‐Yan Zhang, Na Li, Qi Li, Cheng‐Lin Deng, Bo Zhang, Xiaodan Li, Han‐Qing Ye · 2022 · PLoS neglected tropical diseases
  28. Smart healthcare: A prospective future medical approach for COVID-19
    De‐Ming Yang, Tai-Jay Chang, Kai-Feng Hung, Mong‐Lien Wang, Yen‐Fu Cheng, Su‐Hua Chiang, Mei‐Fang Chen, Yi-Ting Liao, Wei-Qun Lai, Kung‐Hao Liang · 2022 · Journal of the Chinese Medical Association
  29. SARS‐CoV‐2 cellular tropism and direct multiorgan failure in COVID‐19 patients: Bioinformatic predictions, experimental observations, and open questions
    Anna A. Valyaeva, Anastasia A. Zharikova, Eugene V. Sheval · 2022 · Cell Biology International
  30. A Review of the Currently Available Antibody Therapy for the Treatment of Coronavirus Disease 2019 (COVID-19)
    Kristin Widyasari, Jin Nam Kim · 2023 · Antibodies
  31. SARS-CoV-2 as an Oncolytic Virus Following Reactivation of the Immune System: A Review
    Joao P. Bounassar-Filho, Laura Boeckler-Troncoso, Jocelyne Cajigas-Gonzalez, Maria Guadalupe Zavala-Cerna · 2023 · International Journal of Molecular Sciences
  32. O-Linked Sialoglycans Modulate the Proteolysis of SARS-CoV-2 Spike and Likely Contribute to the Mutational Trajectory in Variants of Concern
    Edgar González-Rodríguez, Mia I. Zol-Hanlon, Ganka Bineva‐Todd, Andrea Marchesi, Mark J. Skehel, Keira E. Mahoney, Chloë Roustan, Annabel Borg, Lucia Di Vagno, Svend Kjær et al. · 2023 · ACS Central Science
  33. SARS-CoV-2 Spike Protein Is Capable of Inducing Cell–Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies
    Nina Reuter, Xiaohan Chen, Barbara Kropff, Antonia Sophia Peter, William J. Britt, Michael Mach, Klaus Überla, Marco Thomas · 2023 · Viruses
  34. Structural and functional characteristics of the SARS-CoV-2 Omicron subvariant BA.2 spike protein
    Jun Zhang, Weichun Tang, Hailong Gao, Christy L. Lavine, Wei Kang Shi, Hanqin Peng, Haisun Zhu, Krishna Anand, Matina Kosikova, Hyung Joon Kwon et al. · 2023 · Nature Structural & Molecular Biology
  35. Decreased Interfacial Dynamics Caused by the N501Y Mutation in the SARS-CoV-2 S1 Spike:ACE2 Complex
    Wesam S. Ahmed, Angelin M. Philip, Kabir Hassan Biswas · 2022 · Frontiers in Molecular Biosciences
  36. The adaptation of SARS-CoV-2 to humans
    Eduardo Tosta · 2021 · Memórias do Instituto Oswaldo Cruz
  37. Red Blood Cell-Derived Extracellular Vesicles Display Endogenous Antiviral Effects and Enhance the Efficacy of Antiviral Oligonucleotide Therapy
    Migara Kavishka Jayasinghe, Chang Jian Gao, Gracemary L. R. Yap, Brendon Zhi Jie Yeo, Luyen Tien Vu, Douglas Jie Wen Tay, Wen Xiu Loh, Zhen Qin Aw, Huixin Chen, Cao Dai Phung et al. · 2023 · ACS Nano
  38. Advances, challenges, and opportunities for food safety analysis in the isothermal nucleic acid amplification/CRISPR-Cas12a era
    Pengpeng Xue, Yubo Peng, Renjing Wang, Qian Wu, Qi Chen, Chao Yan, Wei Chen, Jianguo Xu · 2024 · Critical Reviews in Food Science and Nutrition
  39. Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system
    Nina Marí Gual Pimenta de Queiroz, Fabio Vitarelli Marinho, Marcelo Chagas, Luciana C. C. Leite, E. Jane Homan, Mariana T. Q. de Magalhães, Sergio Costa Oliveira · 2020 · Microbes and Infection
  40. Nanoparticles‐assisted delivery of antiviral‐siRNA as inhalable treatment for human respiratory viruses: A candidate approach against SARS‐COV‐2
    Ata Ullah, Javaria Qazi, Lutfur Rahman, Antonios G. Kanaras, Waheed S. Khan, Irshad Hussaın, Asma Rehman · 2020 · Nano Select
  41. SARS-CoV-2 RNA shedding in recovered COVID-19 cases and the presence of antibodies against SARS-CoV-2 in recovered COVID-19 cases and close contacts, Thailand, April-June 2020
    Chintana Chirathaworn, Manit Sripramote, Piti Chalongviriyalert, Supunnee Jirajariyavej, Phatharaporn Kiatpanabhikul, Jatuporn Saiyarin, Chulikorn Soudon, Orawan Thienfaidee, Thitisan Palakawong Na Ayuthaya, Chantapat Brukesawan et al. · 2020 · PLoS ONE
  42. HCoV-NL63 and SARS-CoV-2 Share Recognized Epitopes by the Humoral Response in Sera of People Collected Pre- and during CoV-2 Pandemic
    Elena Rita Simula, Maria Antonietta Manca, Seyedesomaye Jasemi, Sergio Uzzau, Salvatore Rubino, Pierangela Manchia, Angela Bitti, Mario Palermo, Leonardo Antonio Sechi · 2020 · Microorganisms
  43. Molecular-Level Anatomy of SARS-CoV-2 for the Battle against the COVID-19 Pandemic
    Makoto Komiyama · 2021 · Bulletin of the Chemical Society of Japan
  44. Overview of COVID-19 and neurological complications
    Nasrin Hosseini, Shabnam Nadjafi, Behnaz Ashtari · 2021 · Reviews in the Neurosciences
  45. Cardiovascular Injury Due to SARS-CoV-2
    Christina L. Bugert, Victoria R. Kwiat, Isela Valera, Joachim J. Bugert, Michelle S. Parvatiyar · 2021 · Current Clinical Microbiology Reports
  46. Implications of microscale lung damage for COVID-19 pulmonary ventilation dynamics: A narrative review
    Elizabeth D. Dimbath, Veeranna Maddipati, Jennifer Stahl, Kerry B. Sewell, Zachary J. Domire, Stephanie George, Ali Vahdati · 2021 · Life Sciences
  47. Nanobased Platforms for Diagnosis and Treatment of COVID-19: From Benchtop to Bedside
    Elham Bidram, Yasaman Esmaeili, Abbas Amini, Rossella Sartorius, Franklin R. Tay, Laleh Shariati, Pooyan Makvandi · 2021 · ACS Biomaterials Science & Engineering
  48. In silico binding profile characterization of SARS-CoV-2 spike protein and its mutants bound to human ACE2 receptor
    Yuzhao Zhang, Xibing He, Jingchen Zhai, Beihong Ji, Viet Hoang Man, Junmei Wang · 2021 · Briefings in Bioinformatics
  49. SARS-CoV-2 cell entry and targeted antiviral development
    Zi-Nuo Chen, R. Du, Jazmin M. Galván Achi, Li-Jun Rong, Q. Cui · 2021 · Acta Pharmaceutica Sinica B
  50. Therapeutic use of specific tumour necrosis factor inhibitors in inflammatory diseases including COVID-19
    Serena Patel, Meenu Wadhwa · 2021 · Biomedicine & Pharmacotherapy
  51. SARS-CoV 2 spike protein S1 subunit as an ideal target for stable vaccines: A bioinformatic study
    Somakalahalli Narasimhappa Nagesha, Ramesh B.N., Chalapathi Pradeep, K. S. Shashidhara, Thippeswamy Ramakrishnappa, Krishnaprasad B.T., Jnanashree S.M., Manohar M., Arunkumar N., Yallappa et al. · 2021 · Materials Today Proceedings
  52. The virological impacts of SARS-CoV-2 D614G mutation
    Chenxi Wang, You Yi Zheng, Zubiao Niu, Xiaoyi Jiang, Qiang Sun · 2021 · Journal of Molecular Cell Biology
  53. Fruit Bromelain-Derived Peptide Potentially Restrains the Attachment of SARS-CoV-2 Variants to hACE2: A Pharmacoinformatics Approach
    Trina Ekawati Tallei, Fatimawali Fatimawali, Ahmad Akroman Adam, Mona Mohamed Elseehy, Ahmed M. El‐Shehawi, Eman A. Mahmoud, Adinda Dwi Tania, Nurdjannah Jane Niode, Diah Kusumawaty, Souvia Rahimah et al. · 2022 · Molecules
  54. Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing
    Max Luedemann, Daniela Stadler, Cho‐Chin Cheng, Ulrike Protzer, Percy Alexander Knolle, Sainitin Donakonda · 2022 · Computational and Structural Biotechnology Journal
  55. High diversity in Delta variant across countries revealed by genome‐wide analysis of SARS‐CoV‐2 beyond the Spike protein
    Rohit Suratekar, Pritha Ghosh, Michiel J.M. Niesen, Gregory Donadio, Praveen Anand, Venky Soundararajan, AJ Venkatakrishnan · 2022 · Molecular Systems Biology
  56. Possible Role of Matrix Metalloproteinases and TGF-β in COVID-19 Severity and Sequelae
    Gustavo Ramírez-Martínez, Luis Armando Jiménez-Álvarez, Alfredo Cruz‐Lagunas, Sergio Ignacio-Cortés, Itzel Alejandra Gómez-García, Tatiana Sofia Rodrı́guez-Reyna, José Alberto Choreño-Parra, Joaquı́n Zúñiga · 2022 · Journal of Interferon & Cytokine Research
  57. Interaction of Bioactive Compounds of Moringa oleifera Leaves with SARS-CoV-2 Proteins to Combat COVID-19 Pathogenesis: a Phytochemical and In Silico Analysis
    Sahabjada Siddiqui, Shivbrat Upadhyay, Rumana Ahmad, Md. Abul Barkat, Azfar Jamal, Abdulaziz S. Alothaim, Mohd. Zaheen Hassan, Mohammad Akhlaquer Rahman, Md Arshad, Tanveer Ahamad et al. · 2022 · Applied Biochemistry and Biotechnology
  58. Native and activated antithrombin inhibits TMPRSS2 activity and SARS‐CoV‐2 infection
    Lukas Wettstein, Patrick Immenschuh, Tatjana Weil, Carina Conzelmann, Yasser Almeida‐Hernández, Markus Hoffmann, Amy Madeleine Kempf, Inga Nehlmeier, Rishikesh Lotke, Moritz Petersen et al. · 2022 · Journal of Medical Virology
  59. Therapeutic Potential of Myrrh, a Natural Resin, in Health Management through Modulation of Oxidative Stress, Inflammation, and Advanced Glycation End Products Formation Using In Vitro and In Silico Analysis
    Arshad Husain Rahmani, Shehwaz Anwar, Ravindra Raut, Ahmad Almatroudi, Ali Yousif Babiker, Amjad Ali Khan, Mohammed A. Alsahli, Saleh A. Almatroodi · 2022 · Applied Sciences
  60. Novel CYP11A1-Derived Vitamin D and Lumisterol Biometabolites for the Management of COVID-19
    Shariq Qayyum, Radomir M. Slominski, Chander Raman, Andrzej T. Slominski · 2022 · Nutrients
  61. A call for immediate action to increase COVID-19 vaccination uptake to prepare for the third pandemic winter
    Cornelia Betsch, Philipp Schmid, Pierre Verger, Stephan Lewandowsky, Anna Soveri, Ralph Hertwig, Angelo Fasce, Dawn Liu Holford, Paul De Raeve, Arnaud Gagneur et al. · 2022 · Nature Communications
  62. Control of SARS-CoV-2 infection by MT1-MMP-mediated shedding of ACE2
    Xuanming Guo, Jianli Cao, Jian‐Piao Cai, Jiayan Wu, Jiangang Huang, Pallavi Asthana, Sheung Kin Ken Wong, Zi‐Wei Ye, Susma Gurung, Yijing Zhang et al. · 2022 · Nature Communications
  63. Survival-based CRISPR genetic screens across a panel of permissive cell lines identify common and cell-specific SARS-CoV-2 host factors
    Katherine Chan, Adrian Granda Farias, Hunsang Lee, Furkan Guvenc, Patricia Mero, Kevin R. Brown, Henry N. Ward, Maximilian Billmann, Kamaldeep Aulakh, Audrey Astori et al. · 2022 · Heliyon
  64. Application of the zebrafish model in human viral research
    Jie Liu, Xiaoyi Yuan, Chunxin Fan, Guangyong Ma · 2024 · Virus Research
  65. Targeting SARS‐CoV‐2 Spike Protein/ACE2 Protein‐Protein Interactions: a Computational Study
    Davide Pirolli, Benedetta Righino, Maria Cristina De Rosa · 2021 · Molecular Informatics
  66. SARS-CoV-2 serology testing: Progress and challenges
    Aria C. Shi, Ping Ren · 2021 · Journal of Immunological Methods
  67. Interpretable and Predictive Deep Neural Network Modeling of the SARS-CoV-2 Spike Protein Sequence to Predict COVID-19 Disease Severity
    Bahrad Ali Sokhansanj, Zhengqiao Zhao, GAIL L. ROSEN · 2022 · Biology
  68. Channels and Transporters of the Pulmonary Lamellar Body in Health and Disease
    Paul Dietl, Manfred Frick · 2021 · Cells
  69. No Small Matter: A Perspective on Nanotechnology-Enabled Solutions to Fight COVID-19
    Georgia Wilson Jones, Marco P. Monopoli, Luisa Campagnolo, Antonio Pietroiusti, Lang Tran, Bengt Fadeel · 2020 · Nanomedicine
  70. Genetics of COVID-19
    Salmo Raskin · 2020 · Jornal de Pediatria
  71. Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal
    Vítor Borges, Joana Isidro, Helena Cortes Martins, Sílvia Duarte, Luísa Mota‐Vieira, Ricardo B. Leite, Isabel Gordo, Constantino Caetano, Baltazar Nunes, Regina Sá et al. · 2020 · Emerging Microbes & Infections
  72. Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study
    Gema Lizbeth Ramírez-Salinas, Marlet Martínez‐Archundia, José Correa‐Basurto, Jazmín García‐Machorro · 2020 · Molecules
  73. Role of vitamin D in regulating COVID-19 severity—An immunological perspective
    Vandana Kalia, George P. Studzinski, Surojit Sarkar · 2021 · Journal of Leukocyte Biology
  74. Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms
    Baohui Xu, Gang Li, Jia Guo, Toru Ikezoe, Karthikeshwar Kasirajan, Sihai Zhao, Ronald L. Dalman · 2021 · Journal of Vascular Surgery
  75. Animal Models of COVID-19. I. Comparative Virology and Disease Pathogenesis
    Caroline J. Zeiss, Susan R Compton, Rebecca T. Veenhuis · 2021 · ILAR Journal
  76. Effect of clinical isolate or cleavage site mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell–cell fusion
    Chelsea T. Barrett, Hadley E. Neal, Kearstin L. Edmonds, Carole L. Moncman, Rachel Thompson, Jean Mawuena Branttie, Kerri Beth Boggs, Cheng‐Yu Wu, Daisy W. Leung, Rebecca Dutch · 2021 · Journal of Biological Chemistry
  77. COVID-19 in Solid Organ Transplant Recipients: a Review of the Current Literature
    Madeleine R. Heldman, Olivia S. Kates · 2021 · Current treatment options in infectious diseases/Current treatment options in infectious disease
  78. Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses
    Alex Sampson, Jonathan Luke Heeney, Diego M. Cantoni, Matteo Ferrari, Maria Suau Sans, Charlotte L. George, Cecilia Di Genova, Martin Mayora Neto, Sebastian Einhauser, Benedikt Asbach et al. · 2021 · Viruses
  79. Anti-SARS-CoV-2 Strategies and the Potential Role of miRNA in the Assessment of COVID-19 Morbidity, Recurrence, and Therapy
    Maria Narożna, Błażej Rubiś · 2021 · International Journal of Molecular Sciences
  80. The Molecular Interplay between Human Coronaviruses and Autophagy
    Ankit Shroff, Taras Y. Nazarko · 2021 · Cells
  81. Calcium Signaling Pathway Is Involved in the Shedding of ACE2 Catalytic Ectodomain: New Insights for Clinical and Therapeutic Applications of ACE2 for COVID-19
    Artemio García‐Escobar, Silvio Vera, Alfonso Jurado-Román y, Santiago Jiménez‐Valero, Guillermo Galeote, Raúl Moreno · 2022 · Biomolecules
  82. In silico analysis of SARS-CoV-2 proteins as targets for clinically available drugs
    Wallace K. B. Chan, Keith M. Olson, Jesse W. Wotring, Jonathan Z. Sexton, Heather A. Carlson, John R. Traynor · 2022 · Scientific Reports
  83. Integrin/TGF-β1 Inhibitor GLPG-0187 Blocks SARS-CoV-2 Delta and Omicron Pseudovirus Infection of Airway Epithelial Cells In Vitro, Which Could Attenuate Disease Severity
    Kelsey E. Huntington, Lindsey Carlsen, Eui Young So, Matthias Piesche, Olin D. Liang, Wafik S. El‐Deiry · 2022 · Pharmaceuticals
  84. Hydroxypropyl-beta-cyclodextrin (HP-BCD) inhibits SARS-CoV-2 replication and virus-induced inflammatory cytokines
    Bruno Braz Bezerra, Gustavo Peixoto Duarte da Silva, Sharton Vinícius Antunes Coelho, Isadora Alonso Corrêa, Marcos Romário Matos de Souza, Keylla Vitória Gomes Macedo, Bruna Machado Matos, Amílcar Tanuri, Flavio Lemos Matassoli, Luciana Jesus da Costa et al. · 2022 · Antiviral Research
  85. SARS-CoV-2, COVID-19, and Reproduction: Effects on Fertility, Pregnancy, and Neonatal Life
    Julien Harb, Nour Debs, Mohamad Rima, Yingliang Wu, Zhijian Cao, Hervé Kovacic, Ziad Fajloun, Jean‐Marc Sabatier · 2022 · Biomedicines
  86. Development and application of ribonucleic acid therapy strategies against COVID-19
    Ning Lin, Mujiexin Liu, Yushu Gou, Yue Yang, Bifang He, Jian Hua Huang · 2022 · International Journal of Biological Sciences
  87. Novel Regioselective Approach to Cyclize Phage-Displayed Peptides in Combination with Epitope-Directed Selection to Identify a Potent Neutralizing Macrocyclic Peptide for SARS-CoV-2
    Joshua Trae Hampton, Tyler J. Lalonde, Jeffery M. Tharp, Yadagiri Kurra, Yugendar R. Alugubelli, Christopher M. Roundy, Gabriel L. Hamer, Shiqing Xu, Wenshe Ray Liu · 2022 · ACS Chemical Biology
  88. A chromosome-level genome assembly reveals genomic characteristics of the American mink (Neogale vison)
    Karim Karimi, Duy Ngoc, Jingy Wang, John Easley, Shima Borzouie, Mehdi Sargolzaei, Graham Stuart Plastow, Zhiquan Wang, Younes Miar · 2022 · Communications Biology
  89. The effects of amino acid substitution of spike protein and genomic recombination on the evolution of SARS-CoV-2
    Letian Fang, Jie Xu, Yue Zhao, Junyan Fan, Jiaying Shen, Wenbin Liu, Guangwen Cao · 2023 · Frontiers in Microbiology
  90. Overview of Nucleocapsid-Targeting Vaccines against COVID-19
    Alexandra Ya. Rak, Исакова-Сивак Ирина Николаевна, Руденко Лариса Георгиевна · 2023 · Vaccines
  91. Comparative Analysis of Nanomechanical Features of Coronavirus Spike Proteins and Correlation with Lethality and Infection Rate
    Yiwen Hu, Markus J. Buehler · 2020 · Matter
  92. One Health: EAACI Position Paper on coronaviruses at the human‐animal interface, with a specific focus on comparative and zoonotic aspects of SARS‐CoV‐2
    Anna D. J. Korath, Jozef Janda, Eva Untersmayr, Milena Sokołowska, Wojciech Feleszko, Ioana Octavia Agache, Ahmed Adel Seida, Katrin Hartmann, Erika Jensen‐Jarolim, Isabella Pali‐Schöll · 2021 · Allergy
  93. Deciphering epigenetic(s) role in modulating susceptibility to and severity of COVID-19 infection and/or outcome: a systematic rapid review
    Sherihan G. AbdelHamid, Aya A. Refaat, Anthony M. Benjamin, Laila A. Elmawardy, Lougine A. Elgendy, Mark M. Manolly, Nada Abd Elmaksoud, Nourhan Sherif, Nadia Μ. Hamdy · 2021 · Environmental Science and Pollution Research
  94. Polyphenolic Natural Products Active In Silico Against SARS-CoV-2 Spike Receptor Binding Domains and Non-structural Proteins - A Review
    Allan Patrick G. Macabeo, Mark Tristan J. Quimque, Kin Israel Notarte, Xela Amor Adviento, Mikhail Harvey Cabunoc, Von Novi de Leon, Felippe Steven Louis G. Delos Reyes, Eiron John Lugtu, Joe Anthony Manzano, Sofia Nicole Monton et al. · 2021 · Combinatorial Chemistry & High Throughput Screening
  95. Conservation and Enhanced Binding of SARS-CoV-2 Omicron Spike Protein to Coreceptor Neuropilin-1 Predicted by Docking Analysis
    Piyush Baindara, Roy Dinata, Santi M. Mandal, Adam G. Schrum · 2022 · Infectious Disease Reports
  96. Identification of Entry Inhibitors against Delta and Omicron Variants of SARS-CoV-2
    R. K. Lee, Tian-Neng Li, Sui-Yuan Chang, Tai-Ling Chao, Chun-Hsien Kuo, Maxwell Pan, Yu-Ting Chiou, Kuan-Ju Liao, Yi Yang, Yi-Hsuan Wu et al. · 2022 · International Journal of Molecular Sciences
  97. Attenuation of SARS-CoV-2 infection by losartan in human kidney organoids
    Rahmani, Waleed, Chung, Hyunjae, Sinha, Sarthak, Bui-Marinos, Maxwell P., Arora, Rohit, Jaffer, Arzina, Corcoran, Jennifer A., Biernaskie, Jeff, Chun, Justin · 2022 · iScience
  98. Triazolopyrimidine Derivatives: An Updated Review on Recent Advances in Synthesis, Biological Activities and Drug Delivery Aspects
    Ahmed S. Abdelkhalek, Mohamed S. Attia, Mohammad Amjad Kamal · 2023 · Current Medicinal Chemistry
  99. Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of Protection
    Kimia Sobhani, Susan C. Cheng, Raquel A. Binder, Nicholas John Mantis, James M. Crawford, Nkemakonam C. Okoye, Jonathan G. Braun, Sandy Y. Joung, Minhao Wang, Gerard Lozanski et al. · 2023 · Vaccines
  100. Molecular characterization of SARS-CoV-2 nucleocapsid protein
    Yanping Huang, Junkai Chen, Siwei Chen, Congcong Huang, Bei Li, Jian Li, Zhixiong Jin, Qiwei Zhang, Pan Pan, Weixing Du et al. · 2024 · Frontiers in Cellular and Infection Microbiology